This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0539U only for PredicineCARE™ Assay from Predicine Inc. This test for solid tumors analyzes cell–free circulating tumor DNA (ctDNA) from whole–blood samples using next–generation sequencing (NGS). It evaluates 152 genes to detect different types of genetic changes, including single–nucleotide variants (small changes in the DNA sequence), insertions and deletions (adding or removing DNA segments), gene rearrangements (changes in the order of DNA segments), copy number alterations (changes in the number of copies of a gene), and microsatellite instability (a condition where repetitive DNA sequences become unstable). The test provides information on genetic mutations that may have treatment options.
For clinical responsibility, terminology, tips and additional info
start codify free trial.